Abiopharma

🔍 Duprey Lauren Rusckowski (Executive)

Company: TAKEDA PHARMACEUTICAL CO LTD (TAK)

Report Date: 2026-04-27

Detailed Transactions and Holdings:

• Acquired 59,990 shares of American Depositary Shares (Direct)
  Date: 2026-04-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 228,503.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones. On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above.
• F2: Includes 146,762 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (100,658 shares), July 1, 2027 (30,488 shares) and July 1, 2028 (15,616 shares).